Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Aclaris Therapeutics, Inc."
Count: 31
Selected: 0
NCT IDTitle
NCT05216224ATI-450 vs Placebo in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
NCT05432596Study of ATI-1777 in Patients 12 to 65 Years Old With Moderate or Severe Atopic Dermatitis
NCT05279417ATI-450 Plus MTX Versus Placebo Plus MTX in Patients With Moderate to Severe Active RA
NCT05511519Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
NCT04598269Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis
NCT04524858Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)
NCT04247815Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA
NCT03495817A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution
NCT02260180Study of A-101 for the Treatment of Seborrheic Keratosis
NCT03468855A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo
NCT03812510Safety Study of A-101 Topical Solution for the Treatment of Common Warts
NCT03691831A Study of A-101 Topical Solution for the Treatment of Common Warts
NCT03759340ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)
NCT03687372Study of A-101 Topical Solution for the Treatment of Common Warts
NCT03594227ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
NCT03315689Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)
NCT03354637A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata
NCT03224598A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra
NCT03585296A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
NCT03551821Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
NCT03487588An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses
NCT03380390Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea
NCT03148691A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis
NCT03210337A Phase2 of A-101 Topical Solution in Subjects With Common Warts
NCT03278028A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts
NCT02160626Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis
NCT01986920Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis
NCT02669862A Study of A-101 Solution in Subjects With Common Warts.
NCT02667288An Open-Label Safety Study of A-101 Solution
NCT02667275A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis
NCT02667236A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.